Lipitor woes take toll on Pfizer
July 19, 2007Sales and Marketing
Sales of Pfizer's flagship brand Lipitor suffered in the second quarter, contributing to a 20% drop in profits.The company began …
Woman wins court battle for Avastin treatment
July 19, 2007Sales and Marketing NICE, avastin
A woman with bowel cancer has won her High Court battle for access to the drug Avastin, overturning a decision …
Spending pushes Actelion into loss but boom continues
July 19, 2007Sales and Marketing
Specialist pharma company Actelion has registered a loss of 53 million Swiss francs ($44 million) for the first half of …
Roche splits top roles
July 19, 2007Sales and Marketing
Roche's Franz Humer is stepping down as chief executive to concentrate on his role as chairman.In splitting the top jobs, …
Generic pressure curbs Novartis growth
July 17, 2007Sales and Marketing
Swiss pharma company Novartis has posted sales growth of 14% for the first half of 2007, but growing pressure from …
Doctors defy NICE as Alzheimer’s spending rises
July 17, 2007Sales and Marketing
UK Alzheimer's patients may not lose access to drug treatment, despite restrictive NICE guidance.Prescribing of Alzheimer's drugs has increased by …
Newly merged Bayer Schering launched in the UK
July 17, 2007Sales and Marketing
Bayer has officially launched its new UK pharmaceutical division, following last year's acquisition of Schering Health Care.Called Bayer Schering Pharma, …
A guarded yes to Gardasil – and a door open to Cervarix
July 17, 2007Sales and Marketing
After 18 months of deliberation by an expert committee, the UK government has agreed in principle that girls aged 12-13 …
Doctors free to overrule NICE decisions, claims charity
July 17, 2007A patient group is urging doctors to exercise their clinical judgement to overrule NICE guidance which restricts access to Alzheimer's …
The gloves come off for ABPI and NHS fight
July 17, 2007ABPI, prescribing incentives
An unprecedented legal action by the pharmaceutical industry against the government could reach the High Court within the next few …
Latest news from Datamonitor
July 16, 2007Research and Development, Sales and Marketing
Antisoma drops ovarian cancer drugCancer drug developer Antisoma says new data from its Phase II trial of ASA404 showed that …
Time is money in R&D
July 16, 2007Research and Development clincial trials, drug development, productivity
There is a much-quoted statistic, which has become so hackneyed that it's largely ignored these days, but while you are …
Radical revamp of NHS in London proposed
July 13, 2007A review of the NHS in London has recommended setting up a network of 150 'polyclinics' to take on much …
FDA approves first Alzheimer’s patch
July 13, 2007Sales and Marketing
The FDA has approved Novartis' Exelon Patch, the first ever skin patch treatment for Alzheimer's disease.Novartis said the once-daily treatment …
Independent PR agency Chandler Chicco acquired
July 13, 2007Medical Communications, Sales and Marketing Chandler Chicco, inVentiv Health
The world’s largest private healthcare PR firm Chandler Chicco Agency has been bought out by US marketing group inVentiv Health …
Piramed and Domainex named among best of British biotech
July 12, 2007Research and Development Piramed, domainex
Piramed and Domainex are among the cutting-edge companies which have been recognised as the best of the UKs biotech sector.UK …
Janssen’s Invega approved in Europe
July 12, 2007Sales and Marketing
Janssen-Cilag's once-daily schizophrenia treatment, Invega, has been granted European approval, making it the first oral, prolonged-release drug for the condition …
NICE reverses decision on Alimta
July 11, 2007Sales and Marketing
Patients with the deadly type of lung cancer called mesothelioma will now be able to receive Lilly's Alimta after NICE …
Remote Control
July 9, 2007Business Services home working, recruitment, remote working
Vorsprung durch technik? Technological advances have allowed employees to spend increasing amounts of time working remotely away from the office. …
Latest news from Datamonitor
July 9, 2007Research and Development, Sales and Marketing
Genzyme says osteoarthritis treatment misses trial goalsGenzyme has reported that its trial of hylastan in treating pain in patients with …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
